OneMedNet’s iRWD platform can securely de-identify, search, and curate the clinical data. Credit: Antonio Marca / Shutterstock.

OneMedNet, a curator of regulatory-grade real world data (RWD), has integrated AI technology into de-identification processes to increase efficiency.

As a result of the integration, the company has streamlined the de-identification of patient data and reduced operational costs.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The technological enhancement allows OneMedNet to process large volumes of clinical data in minutes, a task that previously took hours.

With the introduction of AI, the company not only optimises accuracy but accelerates the delivery of regulatory-grade, de-identified datasets to Life Science organisations.

This has resulted in up to a fivefold increase in speed for the end-to-end data curation process, significantly improving service delivery times.

OneMedNet CEO and president Aaron Green said: “The integration of AI into our de-identification processes not only enhances our data privacy but also significantly boosts our operational efficiency, allowing us to quickly provide high-quality, de-identified datasets to our customers.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Furthermore, AI has enabled us to respond to sales inquiries much faster, improving our customer service and overall business performance.”

The AI-driven de-identification process is a key feature of the company’s iRWD platform, which is designed to provide secure, comprehensive management of clinical data types, including laboratory results, electronic health records, and medical imaging.

This platform is intended to securely de-identify, search, and curate the clinical data to its medical device, drug and imaging/diagnostic AI development customers.

It is said to meet the clinical requirements across various domains, including oncology and rare diseases.